Regeneron (REGN) announces EMA Issues Advice on its Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients

Go back to Regeneron (REGN) announces EMA Issues Advice on its Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
Regeneron (NASDAQ: REGN) Delayed: 815.63 -12.09 (1.46%)
Previous Close $827.72    52 Week High $592.36 
Open $814.36    52 Week Low $325.35 
Day High $821.17    P/E 214.08 
Day Low $799.42    EPS $3.81 
Volume 88,920